Truist Securities Starts Altimmune (ALT) at Buy

March 18, 2026 3:53 PM EDT Send to a Friend
(Updated - March 18, 2026 3:53 PM EDT)

Truist Securities analyst Srikripa Devarakonda initiates coverage on Altimmune (NASDAQ: ALT) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login